Monte Rosa Therapeutics, Inc.GLUENASDAQ
Loading
Direct costs attributable to producing goods sold
5Y CAGR
+50.8%/yr
Long-term compound
Percentile
P67
Within normal range
vs 5Y Ago
7.8x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $4.18M | -48.5% |
| 2024 | $8.12M | +30.5% |
| 2023 | $6.22M | - |
| 2022 | $0.00 | - |
| 2021 | $0.00 | -100.0% |
| 2020 | $537000.00 | +645.8% |
| 2019 | $72000.00 | - |